RO

Roche Holding AG (ROG)

HealthcareDrug Manufacturers - General
324.90CHF
+4.13%
Magic Rank
#8
Earnings Yield
7.1%
Return on Capital
179.6%
Market Cap
256.4B

Performance vs S&P 500 (5Y)

ROG.SW
S&P 500

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Magic Formula Analysis

Enterprise Value272.9B
Market / Universe
ch
Switzerland

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio20.11
Dividend Yield3.1%
Debt to Equity0.49
Gross Margin30.0%